Navigation Links
Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
Date:3/6/2009

CORONA, Calif., March 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that it has reached a settlement with Elan Corporation, Plc on outstanding patent litigation related to Watson's generic version of Naprelan(R) (naproxen sodium) tablets.

Under the terms of the agreement, Watson will pay Elan $18 million in full settlement of all disputes related to Watson's development, manufacturing, marketing and sale of its naproxen sodium product. Watson also has agreed not to market or sell its naproxen sodium product until the expiration or final finding of invalidity or unenforceability of U.S. Patent No. 5,637,320. Other details concerning the settlement have not been disclosed.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes generic and specialty brand pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceutical's Web site at http://www.watson.com.

Watson's Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Watson's current expectation
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
2. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
3. Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
4. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
5. Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
6. U.S. Workers Taking Steps to Lower Medical Costs, Watson Wyatt Survey Finds
7. China Shenghuo Announces Additional Roll-Out of 12 Ways Cosmetics Products to Watsons Stores
8. Driving Consumer Engagement Is Focus of Address by Healthfitness Chief Medical Officer at Watson Wyatt Health Care Solutions Event
9. Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg
10. Watson Enters Into Agreement to Acquire Products Related to Tevas Proposed Acquisition of Barr
11. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... on your genes? Researchers from The Miriam Hospital,s Weight Control ... "obesity genes" tend to eat more meals and snacks, consume ... of high fat, sugary foods. , Their study, published online ... appearing in the June issue, reveals certain variations within the ... to obesity may play a role in eating habits ...
(Date:5/23/2012)... study at Karlstad University in Sweden shows that phthalates ... bodies. Phthalates are substances suspected to cause asthma and ... The study shows that children can ingest these softening ... the skin. , Phthalates are a group of chemical ... number of common consumer goods such as toys, cleaning ...
(Date:5/23/2012)... WEDNESDAY, May 23 (HealthDay News) -- The use ... reduced through a multi-pronged approach that includes more ... relatives, according to a new German study. ... ineffective, physical restraints such as bed rails and ... A recent survey found that the rate of ...
(Date:5/23/2012)... Researchers in the United Kingdom have determined ... anti-inflammatory properties, can be an effective treatment option ... a life-threatening complication that occurs in the majority ... is the leading cause of mortality after the ... when the body repeatedly rejects the transplanted lung ...
(Date:5/22/2012)... trials (RCTs) are critical for determining effectiveness of ... scant support for these studies compared with other ... ( Canadian Medical Association Journal ). , ... Sciences, Hamilton, Ontario, with Dr. John Cairns, University ... appendix that Canada should provide better financial support ...
Breaking Medicine News(10 mins):Health News:'Obesity genes' may influence food choices, eating patterns 2Health News:Phthalates in PVC floors taken up by the body in infants 2Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Canada should significantly increase its funding of randomized clinical trials 2
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) ... its FDA-approved diabetes drugs, BYETTA(R) (exenatide) injection and SYMLIN(R) ... exenatide once weekly at the American Diabetes Association,s (ADA,s) ... from June 5 to 9. The company will also ...
... evaluation and human resource management assessment tools, has released a ... findings in this report address the reasons front line managers ... specific remedies and action steps to avoid derailment and improve ... ...
... cover claims between November 2007 and October 2008, Only 2% of critical ... claims - cancer, heart related and stroke , ... Edinburgh, UK (PRWEB) ... in life insurance *, has today published details of its critical ...
... tests to identify specific strains of infectious prions, which cause ... animals and humans, can take anywhere from six months to ... put human populations at risk. , Now, a group of ... a new method that cuts this critical time lag by ...
... DaVita Inc. (NYSE: DVA ) ... elected to the Company,s Board of Directors. (Logo: ... is the former President of American Express International, ... she ran the Consumer Card business across 12 ...
... May 28 Annoying seasonal allergies is now a ... homes encourage allergens to nest in the home. Indoor ... the myriad of chemicals, synthetic materials and impurities. To ... truly revolutionary approach to home ventilation and eliminates allergens.The ...
Other Medicine News:Health News:Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009 2Health News:Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009 3Health News:Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009 4Health News:Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009 5Health News:Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009 6Health News:Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009 7Health News:Profiles International Releases New Report on Top 5 Management Failures and Remedies for Success 2Health News:Profiles International Releases New Report on Top 5 Management Failures and Remedies for Success 3Health News:Scottish Widows Releases Critical Illness Cover Claims Figures 2Health News:Scripps Florida scientists devise accelerated method to determine infectious prion strains 2Health News:Scripps Florida scientists devise accelerated method to determine infectious prion strains 3Health News:Pamela M. Arway Joins DaVita Board of Directors 2Health News:EZ Breathe(R) Home Ventilation System Expels Allergens, Moisture and Smells 2
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
Inquire...
Inquire...
The Phoresis is a state-of-the-art digital imaging system which allows scanning and storage of electrophoresis results from any Sebia gel including immunofixation. This system provides benefits to an...
... during laparoscopic surgery, will help reduce many ... and loss of distension due to smoke ... from the patient's cavity. This system is ... evacuator that creates a constant closed loop ...
Medicine Products: